Wedbush Reiterates an 'Underperform' on Dendreon (DNDN); New Treatments in Prostate Cancer Could Leave Provenge Behind

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/20/2026

1. BA
2. SPY
3. USO
4. NVDA
5. XFLT
6. GE
7. RTX
8. AMC
9. TRV
10. PSNL

Go back to Wedbush Reiterates an 'Underperform' on Dendreon (DNDN); New Treatments in Prostate Cancer Could Leave Provenge Behind